Neopterin is produced by monocytes and a useful biomarker of inflammatory responses. We found recently in mice that neopterin suppressed erythropoiesis but enhanced myelopoiesis possibly by activating stromal cells, the same phenomenon observed in inflammation. In this study, we investigated whether neopterin affects the proliferation and differentiation of immature erythroid progenitor cells (BFU-E) by stimulating bone-marrow stromal cells in culture. Neopterin decreased the number of colonies of BFU-E formed by unfractionated bone-marrow cells in a semisolid culture system, but increased the number of granulocyte-macrophage progenitor cells (CFU-GM). In contrast, it did not affect numbers of BFU-E or CFU-GM among a lineage-negative (fractionated) bonemarrow-cell population cultured without stromal cells. These results suggest that neopterin decreased the number of colonies of BFU-E by activating bone-marrow stromal-cell function.
Introduction
Neopterin is a metabolite of guanosine triphosphate that is produced in the biopterin synthetic pathway (1) . This metabolite is generated in large amounts by monocytes and macrophages in response to interferon-γ (IFN-γ) (2) . Production of neopterin is increased following infection by viruses, bacteria and parasites (3) . Because its level in body fluid reflects immune responses in vivo, neopterin is regarded as a sensitive marker of the activation of the cellular immune system as well as a prognostic factor and biomarker (3, 4) . However, there is evidence that neopterin also has distinct biological effects (3, 4) .
Neopterin increased the number of colonies of granulocyte-macrophage progenitor cells (CFU-GM) in a semisolid culture system (5) , and when injected intraperitoneally into mice, stimulated myelopoiesis (6) . This stimulation of myelopoiesis in vitro and in vivo is due not to a direct effect of neopterin on hematopoietic stem cells, but rather to an indirect effect mediated by the production by stromal cells of hematopoietic growth factors such as granulocyte macrophage colony stimulating factor (GM-CSF) and interleukin-6 (IL-6) (5, 7). In contrast to its enhancement of myelopoiesis, neopterin suppressed B-lymphopoiesis in vitro and in vivo by inducing the production by stromal cells of predominantly negative regulators such as tumor necrosis factor-α (TNF-α) and IL-6 (8). Furthermore, neopterin also increased the mast cell progenitor pool in the spleen by stimulating stemcell-factor production by splenic stromal cells (9) . We found recently that in mice, neopterin suppressed erythropoiesis but enhanced myelopoiesis possibly by activating stromal cells (10) . In the present study, we investigated whether neopterin affects the proliferation and differentiation of erythroid progenitor cells by stimulating a bone-marrow stromal-cell in culture system as observed in vivo (10) .
Materials and Methods
Mice C57BL/6J mice, female, were purchased from Charles River Japan (Atsugi, Japan). All the mice were housed under specific pathogen-free conditions at 24 ± 1°C and 55 ± 10% relative humidity, under a 12-hr light dark cycle. Autoclaved tap water and food pellets were provided ad libitum. All experimental protocols involving laboratory mice in this study were reviewed by a peer review panel, the Interdisciplinary Monitoring Committee for the Right Use and Welfare of Experimental Animals, established at Nihon University School of Medicine (NUSM), and approved by the Committee for Animal Care and Use at NUSM with the experimental code #101-18009635000-2009. Approved experiments were humanely performed in strict accordance with the Guidelines for the Care and Use of Laboratory Animals, NUSM, Japan.
Agents and antibodies D-(+)-Neopterin was obtained from Sigma (St. Louis, MO). Neopterin was dissolved in 1 N HCl at 1 mg/ml and diluted tenfold with Dulbecco's phosphatebuffered saline (PBS). Hamerlinck reported that the concentration of neopterin was 5.89 ± 1.78 nM in normal human serum (11). Murr et al. found that the mean serum neopterin level in patients with serious infection by Streptococcus pyogenes was 152 nM (range, 71-242 nM) (12) . Thus, we used neopterin at concentrations from 40 nM to 4 µM for the experiment in vitro (7) (8) (9) . Monoclonal antibodies against mouse Mac-1, TER119, Gr-1, Thy1.2, and B220 were purchased from BD PharMingen (San Diego, CA). Sheep anti-rat IgGcoated immunomagnetic beads (Dynabeads M450 sheep anti-rat IgG) were purchased from Dynal (Great Neck, NY).
Preparation of unfractionated bone marrow (BM) cells
BM cell suspensions were prepared by repeatedly flushing the cells from femurs and dispersing them by repeatedly passing them through a 23-gauge hypodermic needle using α-minimum essential medium (α-MEM; Life Technology, Grand Island NY) or Iscove-modified Dulbecco's medium (IMDM; Invitrogen, Carlsbad, CA).
Isolation of Lineage-negative BM cells [Lin (-) BM cells]
The BM cells were washed with α-MEM once, and cell pellets were suspended in 10 mL of 0.86% NH 4 Cl for 5 min at 4°C for the lysis of erythrocytes. The BM cells were then washed twice with α-MEM and mononuclear cells of the BM were obtained. Lin (-) BM cells were collected using the antibodies and immunomagnetic beads as described previously (13) . 
In vitro colony assays
Erythroid burst-colony-forming units (BFU-E) were assayed by suspending mononuclear cells in α-MEM containing 1% methylcellulose, 30% fetal bovine serum(FBS; Hyclone, Logan, UT), 1% deionized bovine serum albumin(BSA), 100 µM 2-mercaptoethanol (2-ME), 2 U/ml of erythropoietin (Kirin Brewery Co,Tokyo,Japan) and 1 ng/mL of IL-3( R&D, Minneapolis, MN) (14) . Colony-forming unit-granulocyte-macrophages (CFU-GM) were assayed by suspending mononuclear cells in MethoCult M 3231 medium (Stem Cell Technologies Inc., Vancouver, B.C.), which consisted of IMDM composed of 1% methylcellulose, supplemented with 30% FBS, 1% BSA, 100 µM 2-ME, 2 mM L-glutamine, and 10 ng/mL of granulocyte macrophage colony stimulating factor (GM-CSF; R&D) (10) . The cells (1-mL aliquots) were plated in 35-mm plastic dishes and incubated at 37°C in a fully humidified atmosphere of 5% CO 2 in air. Triplicate culture plates were assayed, so that the mean and standard deviation of the mean obtained indicate measures of assay quality. BFU-E and CFU-GM were score on day 10 and day 7, respectively.
Statistical analyses
All data are presented as the mean ± SD. Differences among experimental groups were assessed using a one-way analysis of variance (ANOVA). The level of statistical significance was accepted at P< 0.05.
Results and Discussion
To determine whether neopterin affects the proliferation or differentiation of immature BFU-E in vitro, as observed in vivo (9), we cultured unfractionated BM cells in a methylcellulose culture medium containing IL-3, erythropoietin and neopterin at various concentrations, and measured the number of colonies formed (Fig. 1A) . Figure 1A shows the effect of neopterin on BFU-E and CFU-GM in unfractionated BM cells. When neopterin was administered at 40 nM to 4 µM, the number of BFU-E colonies formed by unfractionated BM cells significantly decreased in a dose-dependent manner compared with that in the untreated groups (93.1% for 40 nM, 65.5% for 400 nM; P <0.05 and 50.0% for 4 µM; P <0.005). In contrast, the number of CFU-GM colonies formed by unfractionated BM cells significantly increased in a dose-dependent manner compared with that in the untreated groups (114% for 40nM, 130% for 400 nM; P <0.05 and 150% for 4 µM; P <0.005), as observed in previous experiments (7) .
However, no suppression of BFU-E colony formation or enhancement of CFU-GM colony formation by neopterin was observed when BM cells were fractionated, and Lin (-) BM cells without stromal cells were isolated and seeded with various concentrations of neopterin (Fig. 1B) . These results indicate that the inhibition of BFU-E proliferation and differentiation of unfractionated BM cells is not a direct effect but rather an indirect effect of neopterin, presumably a stromalcell-mediated effect.
We reported recently that the intravenous injection of neopterin into mice increased the gene expression levels for stromal derived factot-1 (SDF-1) in BM (10) . Furthermore, the administration of neopterin to cultured BM stroma cells resulted in an increase of gene expression levels for SDF-1 (10). SDF-1 acts a role as a negative regulator of erythropoiesis, because it significantly reduced the number of BFU-E in a semisolid assay and the inhibitory effect of SDF-1 on glycophorin A-positive erythroid-cell development was mediated by the functional up-regulation of CD95L expression (15) . Taken together, it seems likely that neopterin induced the production of SDF-1 by stromal cells and inhibited the formation of colonies by BFU-E. More studies are required to elucidate the mechanisms underlying neopterin's actions, but the present findings provide evidence that neopterin is a potent regulatory factor for erythropoiesis in BM via the activation of the BM hematopoietic microenvironment during inflammatory processes. 
